Member Exclusive News

The week in industry: UK becoming hub for developing cell and gene therapies

This week: Eli Lily announces agreement to acquire Loxo Oncology, Novartis’ drug given FDA Breakthrough Therapy status and plans for no-deal Brexit released by the MHRA.

Go to the profile of RxNet
Jan 10, 2019

Please sign in or register for FREE

No comments yet.